Consun Pharma (01681) spent HK$1.54 million on October 27 to repurchase 100,000 shares.
Kangzhi Pharmaceutical (01681) announced that on October 27, 2025, the company spent HK$1.54 million to repurchase...
CONSUN PHARMA (01681) issued a notice that on October 27, 2025, the company spent 1.54 million Hong Kong dollars to repurchase 100,000 shares.
Related Articles
US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.
US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.
The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.
US Stock Market Move | Biopharmaceutical company Maplight Therapeutics (MPLT.US) listed on the US stock market, with its stock price rising more than 15.8%.
US Stock Market Move | Strive (ASST.US) surged by 35% in the past 3 trading days, with a total increase of 92%.
The U.S. Department of Energy is partnering with AMD (AMD.US) to build two AI supercomputers to accelerate scientific breakthroughs in nuclear energy, cancer drugs, and more.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
